Home › Funds › Caligan Partners LP › IMCR

Caligan Partners LP position in IMCR

IMMUNOCORE HLDGS PLC · Health Care

Caligan Partners LP reported holding 1,672,141 shares of IMCR (IMMUNOCORE HLDGS PLC) in its Q3 2026 13F filing — a position valued at US$50.6M, representing 3.10% of its reported portfolio and ranking #9 among its reported holdings. Caligan Partners LP has disclosed IMCR holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)1.67M sh
Reported value held$50.65M
Portfolio Weight3.10%
First reportedQ2 2026
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Caligan Partners LP's IMCR position evolved

Caligan Partners LP first disclosed a stake in IMCR in Q2 2026 at 1,381,317 shares (US$43.9M). The position peaked in Q3 2026 at 1,672,141 shares, worth US$50.6M. Across 2 filings, Caligan Partners LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,672,141 shares valued at US$50.6M — an increase of 290,824 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 1.38M $43.86M New
Q3 2026 1.67M $50.65M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMCR and 13F data

IMCR (IMMUNOCORE HLDGS PLC) is a Health Care company. 27 other funds we track also report a position in IMCR — the largest reported positions include RTW INVESTMENTS, LP (US$147.5M), TANG CAPITAL MANAGEMENT LLC (US$87.4M), Bellevue Group AG (US$68.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMCR

All IMCR fund holders →

FAQ

How long has Caligan Partners LP held IMCR?

Caligan Partners LP has disclosed IMCR holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Caligan Partners LP's current position in IMCR?

As of Q3 2026, Caligan Partners LP holds 1.67M shares of IMCR (IMMUNOCORE HLDGS PLC), valued at $50.65M, representing 3.10% of its reported portfolio and ranking #9.

Has Caligan Partners LP been buying or selling IMCR?

In the latest 13F filing (Q3 2026), Caligan Partners LP increased its position in IMCR. The position peaked in Q3 2026 at 1.67M shares.

Which other funds hold IMCR?

Other major institutional holders of IMCR include RTW INVESTMENTS, LP, TANG CAPITAL MANAGEMENT LLC, Bellevue Group AG, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.